Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Understanding the role of Notch signaling in ovarian cancer stem cells
EF 2011-12
Résumé
Ovarian cancer is the leading cause of death from gynecologic cancers and the fifth leading cause of cancer-related deaths among women. Epithelial ovarian cancers represent the majority of ovarian cancers, and the 5-year survival rate for patients with advanced epithelial ovarian cancer is only 15-25%. Currently established therapies are ineffective at treating this disease at advanced stages, primarily due to the development of drug resistance. Cancer stem cells represent a small population of cancer cells within a tumor, that posses the ability to self-renew, and have the potential to generate the diverse cells that comprise the tumor. Cancer stem cells are present in ovarian cancer, and may be responsible for the drug resistance and recurrence displayed by the disease. Emerging evidence suggests that elimination of cancer stem cells will be the key to successful treatment of this disease, however currently used therapies do not adequately target ovarian cancer stem cells. The Notch signaling pathway is a short-range communication system regulated by cell-to-cell contact that is responsible for controlling numerous biological processes, including the fate of the cell. Inhibitors targeting the Notch pathway have been shown to reduce cancer stem cells in several cancer models. Through our research we will determine if Notch signaling promotes ovarian cancer growth and drug resistance, and whether blocking Notch signaling alone or in combination with other treatments can be an effective way to treat ovarian cancer. Results from our research may contribute to the discovery of new therapeutic targets as well as more effective treatments for ovarian cancer, giving hope to patients suffering from this disease, and overall improving the outcomes and quality of their lives.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
253807
Name
Zepeda Nubia I
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Understanding the role of Notch signaling in ovarian cancer stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Stem Cells; Chemoresistance; Flow Cytometry; Monolayer Culture; Notch Inhibitors; Notch Signalling; Ovarian Cancer; Skov3 Cells; Sphere Culture; Xenograft Model
Abstract
Ovarian cancer is the leading cause of death from gynecologic cancers and the fifth leading cause of cancer-related deaths among women. Epithelial ovarian cancers represent the majority of ovarian cancers, and the 5-year survival rate for patients with advanced epithelial ovarian cancer is only 15-25%. Currently established therapies are ineffective at treating this disease at advanced stages, primarily due to the development of drug resistance. Cancer stem cells represent a small population of cancer cells within a tumor, that posses the ability to self-renew, and have the potential to generate the diverse cells that comprise the tumor. Cancer stem cells are present in ovarian cancer, and may be responsible for the drug resistance and recurrence displayed by the disease. Emerging evidence suggests that elimination of cancer stem cells will be the key to successful treatment of this disease, however currently used therapies do not adequately target ovarian cancer stem cells. The Notch signaling pathway is a short-range communication system regulated by cell-to-cell contact that is responsible for controlling numerous biological processes, including the fate of the cell. Inhibitors targeting the Notch pathway have been shown to reduce cancer stem cells in several cancer models. Through our research we will determine if Notch signaling promotes ovarian cancer growth and drug resistance, and whether blocking Notch signaling alone or in combination with other treatments can be an effective way to treat ovarian cancer. Results from our research may contribute to the discovery of new therapeutic targets as well as more effective treatments for ovarian cancer, giving hope to patients suffering from this disease, and overall improving the outcomes and quality of their lives.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zepeda, Nubia I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~